UHS Stock Analysis — Universal Health Services
Sector: Healthcare
AI Verdict
UHS trades at a rock-bottom 6.0x forward earnings—cheap for a hospital operator with real local moats, but the low multiple shows the market doubts even modest 3.8% EPS growth is safe.
Competitive Moat
Universal Health Services operates acute care hospitals and behavioral health facilities, benefiting from high barriers to entry due to regulatory hurdles and the complexity of hospital operations. Its scale and network contracts with insurers make it difficult for new entrants to compete locally.
Summary
UHS stands out for trading at just 6.0x forward earnings while the healthcare sector median is 22x.
Where It Stands
The stock is down -9.39% over the past year, has an RSI of 37.1 signaling it's close to oversold, and trades at 6.0x forward earnings versus the sector's 22x median.
Key Metrics
- RSI: 37.1 — Near Oversold
- Trailing P/E: 6.2x
- Forward P/E: 6.0x
- PEG Ratio: 1.50
- Earnings Growth: +0.0%
- Revenue Growth: +0.1%
- Market Cap: $9.0B
- Dividend Yield: 0.01%
- 1-Year Return: -9.39%
- 52-Week High: $246.33
- 52-Week Low: $140.08
Analyst Consensus
10 Buy · 15 Hold · 1 Sell (26 analysts)
Bull Case
At 6.0x forward P/E and with 3.8% expected EPS growth, you're paying a deep discount for a business with entrenched local market positions.
Bear Case
If the P/E multiple falls from 6.0x to 5x, that would wipe another 17% off the share price even before considering any operational headwinds.
Catalyst to Watch
Watch for regulatory changes or reimbursement rate updates, as any shift here could quickly alter the earnings outlook and justify the low valuation.